Option Care Health Inc. (OPCH)
Here is Why Growth Investors Should Buy Option Care (OPCH) Now
Option Care (OPCH) could produce exceptional returns because of its solid growth attributes.
Earnings Estimates Rising for Option Care (OPCH): Will It Gain?
Option Care (OPCH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
OPCH or CHE: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two stocks is more attractive to value investors?
Option Care Health, Inc. (OPCH) Hit a 52 Week High, Can the Run Continue?
Option Care (OPCH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
After Golden Cross, Option Care (OPCH)'s Technical Outlook is Bright
After reaching an important support level, Option Care Health, Inc. (OPCH) could be a good stock pick from a technical perspective. OPCH recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
Option Care Health, Inc. (OPCH) Q4 2024 Earnings Call Transcript
Call Start: 8:30 January 1, 0000 9:19 AM ET Option Care Health, Inc. (NASDAQ:OPCH ) Q4 2024 Earnings Conference Call February 26, 2025 8:30 AM ET Company Participants Nicole Maggio – Senior Vice President and Corporate Controller John Rademacher – President and Chief Executive Officer Mike Shapiro – Chief Financial Officer Conference Call Participants Matt Larew – William Blair Brian Tanquilut – Jefferies Lisa Gill – JPMorgan Pito Chickering – Deutsche Bank Constantine Davides – Citizens Joanna Gajuk – Bank of America Sarah Conrad – Goldman Sachs Operator Good day and thank you for standing by. Welcome to the Option Care Health Fourth Quarter 2024 Earnings Conference Call.
Option Care (OPCH) Q4 Earnings and Revenues Surpass Estimates
Option Care (OPCH) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.32 per share a year ago.
Will Option Care (OPCH) Beat Estimates Again in Its Next Earnings Report?
Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Option Care Health, Inc. (OPCH) Q3 2024 Earnings Call Transcript
Option Care Health, Inc. (NASDAQ:OPCH ) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Nicole Maggio – Senior Vice President-Finance John Rademacher – President and Chief Executive Officer Mike Shapiro – Chief Financial Officer Conference Call Participants David MacDonald – Truist Constantine Davides – Citizens JMP Securities Lisa Gill – JPMorgan Matt Larew – William Blair Brian Tanquilut – Jefferies Jamie Perse – Goldman Sachs Pito Chickering – Deutsche Bank Joanna Gajuk – Bank of America Operator Good day and thank you for standing by. Welcome to the Option Care Health Third Quarter 2024 Earnings Conference Call.
Option Care (OPCH) Surpasses Q3 Earnings and Revenue Estimates
Option Care (OPCH) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.31 per share a year ago.
OPCH vs. ASTH: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Astrana Health, Inc. (ASTH). But which of these two stocks offers value investors a better bang for their buck right now?
Wall Street Analysts Predict a 31.8% Upside in Option Care (OPCH): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 31.8% in Option Care (OPCH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
